Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes by Hung-Hsin Lin et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Lin et al. World Journal of Surgical Oncology 2014, 12:366
http://www.wjso.com/content/12/1/366RESEARCH Open AccessClinicopathological analysis of colorectal carcinoid
tumors and patient outcomes
Hung-Hsin Lin1,2, Jen-Kou Lin1,2, Jeng-Kai Jiang1,2, Chun-Chi Lin1,2, Yuan-Tzu Lan1,2, Shung-Haur Yang1,2,
Huann-Sheng Wang1,2, Wei-Shone Chen1,2, Tzu-Chen Lin1, Wen-Yih Liang2,3 and Shih-Ching Chang1,2*Abstract
Background: Colorectal carcinoid tumors are often described as being low-grade malignant. The objective of the
current study was to address the clinicopathological features and outcomes of patients with colorectal carcinoid
tumors.
Methods: A total of 63 patients with colorectal carcinoid tumors were identified and evaluated using surgical
pathology files and medical records between January 2000 and June 2012 at the Veterans General Hospital,
Taipei, Taiwan.
Results: The median age of the 63 patients was 57.0 years; 38 (60.3%) were male and 25 (39.7%) female. The
rectum was the most common tumor site (90.5%). Tumor size was 10.8 ± 7.4 mm, ranging from 2 to 50 mm in
diameter. There were 40 patients (63.5%) who received endoscopic treatment for a tumor size of 7.7 ± 4.0 mm,
15 (23.8%) who underwent transanal excision for a mean size of 9.2 ± 4.5 mm and eight (12.7%) who underwent
radical surgical resection (mean size: 29.5 ± 13.0 mm). Lymph node metastasis was significantly associated with
tumor size. Totally distant metastases (liver) were demonstrated in four (6.3%), patients with mean tumor size of
31.3 ± 9.4 mm (20 to 50 mm). The extent of the disease was associated with survival and the five-year overall
survival rate was 92.1%.
Conclusions: With widespread colorectal cancer screening, heightened awareness and improved diagnostic
modalities, the incidence of colorectal carcinoid tumors will continue to increase. We demonstrated that small-sized
colorectal carcinoid tumors and those localized in the mucosa or submucosa may be safely and effectively removed
via endoscopic or transanal local excision.
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Carcinoid tumors are rare, comprising approximately
0.49% of all malignancies [1]. These are the most common
neuroendocrine tumors in the gastrointestinal system and
most incidences occur in the gastrointestinal tract [2], with
the rectum and ileum as the most prevalent tumor sites
[1,3]. Gastrointestinal carcinoids are currently referred
to as gastroenteropancreatic neuroendocrine tumors
(GEP-NETs). Despite several re-classifications of GEP-* Correspondence: changsc@vghtpe.gov.tw
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unless otherwise stated.NETs by the World Health Organization (WHO), the
term ‘carcinoid’ is still used as a synonym for ‘well-dif-
ferentiated NET’ and the term ‘malignant carcinoid’ is
used as a synonym for ‘well-differentiated neuroendo-
crine carcinoma’. Among such tumors, carcinoids of the
colon and the rectum are grouped together in the WHO
classification and are distinguished from those of the
appendix or the ileum. In the WHO classification, colo-
rectal carcinoids are described as ‘low-grade malignant’,
even in the presence of metastasis [4]. Furthermore, the
WHO classification defines colorectal carcinoids as
‘benign’ if the tumors are localized in the submucosa,
measure 20 mm or less and lack vascular invasion [4].
Although most colorectal carcinoids are localized at the
time of diagnosis and have low malignant potential,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have malignant potential, and the recorded incidence of
metastasis for these tumors ranges from 1.7 to 3.4% [5,6].
Results related to crucial determinants for metastasis
in colorectal carcinoids possibly vary in relation to the
small number of cases available in each study. Numerous
studies have reported various indicators for metastasis,
including a tumor size of 10 mm or more or 20 mm or
more, invasion to the muscularis propria, older age, male
gender, tumor site, histological growth pattern and mi-
totic rate [7]. As a result, there has been a disagreement
on the therapeutic strategy for use in colorectal carci-
noids, particularly in relation to whether local excision
or radical resection is suitable for an intermediate tumor
size between 10 and 20 mm [8].
The purpose of this study is to review and analyze the
clinicopathological features of carcinoid tumors of the
colon and rectum at a single institution over a 12-year
period.
Methods
Patients and clinical data
We retrospectively identified patients using our institu-
tion’s pathology database and obtained the corresponding
medical records. A total of 63 patients with colorectal
carcinoids were enrolled at the Taipei Veterans General
Hospital between January 2000 and June 2012. The inves-
tigation was approved by the local ethics committee.
Clinical data were prospectively recorded in detail
and stored in electronic files. The data base included:
(1) name, gender, age, family history and major medical
problems of each patient; (2) location, size, gross appear-
ance, stage, differentiation and important pathological
prognostic features of the tumor and (3) type of operation,
complications, recurrence and follow-up conditions. Pa-
thologic staging of the disease was performed according
to the American Joint Committee on Cancer (AJCC) Sta-
ging Manual, seventh edition, after review of the surgical
specimen and investigation of distant metastases [4].
Rectal carcinoids were defined as tumors located within
15 cm of the anal verge, whereas tumors more than 15 cm
above the anal verge were regarded as colonic carcinoids.
The tumors were classified into three groups according to
tumor size: (1) a tumor diameter of less than 10 mm; (2) a
tumor diameter between 10 and 20 mm and (3) a tumor
diameter of over 20 mm. Tumor sizes were confirmed
through pathology reports. In cases where the tumor size
was not clearly described in the pathology report, the size
was determined according to the colonoscopy report.
Treatment methods were classified as endoscopic resec-
tion, transanal resection and radical operation.
All patients were followed up on between three and
six months after surgery during the first three years,
and annually thereafter. Digital examination, chest X-ray,abdominopelvic ultrasound or computed tomography (CT)
scan were used. Recurrence was defined as a local or distant
disease diagnosed more than three months after the initial
surgery, proven by pathological confirmation or progres-
sively increasing size in imaging studies. Survival time was
defined as the time elapsed from the date of diagnosis of
the carcinoid tumor until death from all causes, or until
30 November 2013, which was the final date of the ana-
lysis used in this study.
Statistical analysis
The statistical endpoint used in our analysis was patient
overall survival from the date of treatment. Group distri-
bution for each clinicopathological trait was compared
using the two-tailed Fisher’s exact test and the chi-square
test. Numerical values were compared using the Student’s
t-test and data are expressed as mean ± standard deviation
(SD). Kaplan-Meier survival curves were constructed and
compared using the log-rank test and multivariate analysis
was performed using the Cox proportional hazard model.
Statistical analyses were performed using the SPSS pack-
age (version 16.0 for Windows, SPSS, Chicago, Illinois,
United States).
Results
A total of 63 patients were enrolled in this study and the
population consisted of 38 males (60.3%) and 25 females
(39.7%). The mean age at tumor resection was 57.0 ±
12.5 years (range: 26 to 87 years) and the male-to-female
ratio was 1.52:1. The mean tumor diameter was 10.8 ±
7.4 mm (range: 2 to 50 mm). The clinicopathological fea-
tures are outlined in Table 1 and include patient age at
diagnosis, gender, tumor location, tumor size and treat-
ment (endoscopic resection, local excision and radical
operation). The distribution of surgical methods and
tumor size of colorectal carcinoid tumors is showed in
Table 2. No patient had carcinoid syndrome at diagnosis.
At diagnosis, 49 patients (77.8%) were asymptomatic. The
most common presenting symptom was bloody stool (six
patients, 9.8%). The other main symptoms included
diarrhea (three patients, 4.9%), weight loss (two patients,
3.3%), a palpable anal mass (two patients, 3.3%) and con-
stipation (one patient, 1.6%).
A total of nine patients were diagnosed as having
lymph node metastasis by pathologic investigation or
imaging studies. Six patients who underwent low anterior
resection (LAR) were identified by histological examin-
ation as having lymph node metastasis, and two patients
who underwent only endoscopic resection because of
unresectable distant metastasis were suspected of having
lymph node metastasis on the basis of CT scans. One
patient suffered obstruction of the colon and underwent a
transverse loop colostomy, but later died from unresect-
able distant metastasis.
Table 3 Rate of lymph node metastasis in 63 colorectal
carcinoid tumors
Tumor size (mm) Total (n = 63) Rectum (n = 57) Colon (n = 6)
<10 0/41 0/37 0/4
10 - 20 1/10 (10.0) 1/10 (10.0) -
>20 7/12 (58.3) 7/10 (70.0) 0/2
Total 8/63 (12.7) 8/57 (14.0) 0/6
The values in parentheses are presented as percentages.
Table 1 Distribution of demographic and clinical








Age (mean ± SD, years) 57.0 ± 12.5 57.2 ± 12.6 54.5 ± 10.8 1.000
<65 42 (66.7) 38 (66.7) 4 (66.7)
≥65 21 (33.3) 19 (33.3) 2 (33.3)
Gender 1.52: 1 0.738
Male 38 (60.3) 34 (59.6) 4 (66.7)
Female 25 (39.7) 23 (40.4) 2 (33.3)
Tumor size
(mean ± SD, mm)
10.8 ± 7.4 10.1 ± 6.4 17.2 ± 15.2 0.414
<10 41 (65.1) 37 (65.0) 4 (66.7)
10 - 20 10 (15.9) 10 (17.5) 0 (0.0)
≥20 12 (19.0) 10 (17.5) 2 (33.3)
Treatment 0.149
Endoscopic resection 40 (63.5) 36 (63.2) 4 (66.7)
Local excision 15 (23.8) 15 (26.3) 0 (0.0)
Radical operation 8 (12.7) 6 (10.5) 2 (33.3)
The values in parentheses are presented as percentages.
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ated with tumor size. No lymph node metastasis was
observed for tumors smaller than 10 mm, 10% lymph
node metastasis was observed for tumors between 10
and 20 mm and 58.3% was observed for tumors larger
than 20 mm (Table 3). Distant metastasis at diagnosis
was assessed through CT scans or pathological examina-
tions in four cases. All patients with distant metastasis
had tumors larger than 20 mm (Table 4). Results of the
TNM stage classification according to the AJCC are
shown in Table 5.
The mean length of the follow-up period in this study
was 77.1 months. Two patients were lost to follow-up.
The five-year overall survival rate was 92.1%. For patients
with tumors smaller than 20 mm, the five-year overall sur-
vival rate was 94.0%, which was significantly better than
those with tumors larger than 20 mm (83.3%; P = 0.003)
(Figure 1). However, if the cut-off value of the tumor size
was defined as 10 mm, the five-year overall survival ratesTable 2 The distribution of surgical methods and tumor
size of colorectal carcinoid tumors
Tumor size (mm) Surgical methods
Endoscopic Local excision Radical operation
<10 30 10 1
10 - 20 7 2 1
>20 3 3 6
Total 40 15 8were observed to be similar between patients with tu-
mors larger than, and less than 10 mm (90.9 versus 92.1%;
P = 0.08).
For the 10 patients with tumors between 10 and
20 mm, seven patients underwent colonoscopic resec-
tion, two patients underwent transanal excision, and one
patient received radical low anterior resection. During
the follow-up period, a 76-year-old male patient devel-
oped local recurrence in the rectum and underwent low
anterior resection for a 2.0-cm-sized rectal carcinoid.
The original pathology revealed invasion of the muscularis
propria and two out of 12 lymph nodes were positive for
metastasis.
Overall, seven patients in the cohort (11.1%) had a syn-
chronous second primary tumor at the time of carcinoid
diagnosis. This included five patients with colorectal ade-
nocarcinoma, one patient with pancreatic adenocarcin-
oma and one patient with endometrial adenocarcinoma.
Discussion
In general, the incidence of carcinoid tumors of the colon
is reported to be very low and comprises between 4 and
8% of all carcinoid tumors in the digestive system [1,8,9].
With widespread colorectal cancer screening, heightened
awareness and improved diagnostic modalities, the inci-
dence of early detection of colorectal carcinoid tumors
should continue to increase. Although our study was lim-
ited to the colon and the rectum, a tumor incidence of
9.5% was observed in the colon, which is slightly higher
than the generally accepted incidence rate. The predo-
minance of males over females with rectal carcinoids was
observed by Yoon et al. [10] (ratio 1:15), Konishi et al.
[8] (ratio 1:2.2), and Jetmore et al. [11] (ratio 1:1.7).Table 4 Rate of distant metastasis in 63 colorectal
carcinoid tumors
Tumor size (mm) Total (n = 63) Rectum (n = 57) Colon (n = 6)
<10 0/41 0/37 0/4
10 - 20 0/10 0/10 -
>20 4/12 (33.3) 4/10 (40.0) 0/2
Total 4/63 (6.3) 4/57 (7.0) 0/6
The values in parentheses are presented as percentages.
Table 5 TNM staging of colorectal carcinoid tumors
according to AJCC, seventh edition (n = 63)
TNM stage (clinical or pathological) Number (%)
I T1aN0M0 41 (65.1)
T1bN0M0 9 (14.3)
IIa T2N0M0 4 (6.3)
IIb T3N0M0 1 (1.6)
IIIa T4N0M0 0
IIIb Any T, N1M0 4 (6.3)
IV Any T, any N, M1 4 (6.3)
T1, tumor invades lamina propria or submucosa and size ≤ 2 cm; T1a, tumor
size < 1 cm in greatest dimension; T1b, tumor size 1 to 2 cm in greatest
dimension; T2, tumor invades muscularis propria or size > 2 cm with invasion
of lamina propria or submucosa; T3, tumor invades through the muscularis
propria into the subserosa, or into non-peritonealized pericolic or perirectal
tissues; T4, tumor invades peritoneum or other organs; N0, no regional lymph
node metastasis; N1, regional lymph node metastasis; M0, no distant metastasis;
M1, distant metastasis.
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study (ratio 1:1.52). Carcinoid syndrome was not observed
in the patients in our study, which corresponds to prior
observations that most colorectal carcinoids are non-
functioning and that carcinoid symptomatology is rare
(less than 5%) [7].
In the recently revised AJCC cancer staging, carcinoid
tumors are classified as a malignant disease. The stage
classifications are based on tumor size, the involved layer
of the bowel wall and the presence or absence of lymph
node or distant metastasis. According to this staging
system, our series of cases are classified into 48 stage
I cases, four stage IIa cases, one stage IIb case, no IIIaFigure 1 Kaplan-Meier plot illustrating five-year overall survival by tucases, four stage IIIb cases and four stage IV cases. The
staging results reflect that most cases were early lesions
and were incidentally detected by colonoscopy screening.
A population-based study in Japan reported lymph
node metastasis of 3.7% for rectal carcinoids with sizes
of 5 mm or less, and 9.7% lymph node metastasis for
tumors with sizes of less than 10 mm [9]. These results
complicate decisions regarding treatment methods, even
in small-sized rectal carcinoids. In our study, only one
patient with a rectal carcinoid size between 10 and 20 mm
developed regional lymph node metastasis (10.0%). How-
ever, if lymph node metastasis is to be accurately pre-
dicted, additional studies on the risk factors are required
and treatment methods should be determined considering
various risk factors [2,12].
Although tumor size is often cited as the most import-
ant prognostic indicator for carcinoid tumors, the best
indicators are actually the evidence of invasive growth
and the presence of regional or distant metastasis. In our
study, no cases of distant metastasis in patients with a
tumor size of less than 20 mm were observed. The five-
year survival rates for patients with tumor sizes greater
than and less than 20 mm, were 83.3% and 94.0%, res-
pectively (P = 0.003). Li et al. [13] reported that rectal and
sigmoid carcinoids measuring more than 2 cm or those
that invaded muscle layers (T2) or beyond, or those with
distant metastasis had significantly more frequent metas-
tases and a worse survival rate. Patients with these tumors
should be treated aggressively and should not be treated
using excisional biopsy.
In the case of rectal carcinoids, the risk of lymph
node metastasis and distant metastasis varies dependingmor size.
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portant factor in deciding an appropriate treatment
method. The reported risk of lymph node metastasis for
rectal carcinoids smaller than 10 mm is usually less than
3%; thus, regional treatment including colonoscopic resec-
tion is appropriate [3]. However, radical surgery is recom-
mended for tumors larger than 20 mm, where the risk of
metastasis is known to be 60 to 80%. Shields et al. [14]
reported that a tumor size of more than 10 mm and
lymphovascular invasion were significantly associated with
the presence of nodal disease, rendering mesorectal exci-
sion advisable. Treatment methods for tumors with sizes
between 10 and 20 mm are controversial and no estab-
lished treatment guideline exists.
In our present study, there was no lymph node metas-
tasis observed in relation to tumors smaller than 10 mm,
10% in relation to tumors between 10 and 20 mm and
58.3% in relation to tumors larger than 20 mm. Although
we are unable to draw specific treatment recommen-
dations based on the results of the current study because
of its retrospective nature and small numbers in each sub-
group, it appears that rectal carcinoids measuring less
than 10 mm can be safely managed by local excision. In
addition, local excision is usually recommended for tu-
mors between 10 and 20 mm, but radical surgery should
be considered if there is evidence of lymph node me-
tastasis or lymphovascular invasion on biopsy. In con-
trast, for tumors larger than 20 mm, radical surgery is
mandatory. To rule out distant metastasis, imaging
studies, such as CT or magnetic resonance imaging, are
recommended for patients with rectal carcinoids larger
than 20 mm.
In this study, we discovered that seven patients (11.1%)
had a synchronous second primary tumor at the time of
carcinoid diagnosis. Associated malignancies were fre-
quently identified in conjunction with carcinoids in the
rectum and/or sigmoid (18 of 141 patients; 12.8%) [13].
Of all the gastrointestinal tract carcinoids, colorectal carci-
noids are reported to have a rate of second primary ma-
lignancy in the range of 5 to 32%. The most common site
of associated non-carcinoid malignancies was the gastro-
intestinal tract, which involved between 32 and 62%
of all tumors, followed by the genitourinary tract
(range: 9 to 22%) and the lung and/or bronchial sys-
tem (range: 9 to 13%) [11,13,15-18]. The etiology for
high risk of second primary neoplasms associated
with carcinoid tumors remains unclear. Thus, our data
and those from other studies strongly suggest that when
a carcinoid tumor is identified in a patient, there is a
need for close surveillance of the gastrointestinal tract,
respiratory system and genitourinary tract, and that
long-term follow-up is recommended for patients in
order to identify any delayed metastasis or secondary
malignancies.Conclusions
In this study, we demonstrated that patients with small-
sized colorectal carcinoid tumors that are localized in the
mucosa or submucosa may be safely and effectively
removed via endoscopic or transanal local excision. Pa-
tients with colorectal carcinoid tumors generally have a
good prognosis, but long-term follow-up is recommended
for patients with carcinoid tumors in order to identify any
delayed metastasis or secondary malignancies.
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